Vanguard Group Inc Madrigal Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,833,768 shares of MDGL stock, worth $566 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,833,768

Previous 1,806,704 1.5%

Holding current value

$566 Million

Previous $506 Million 23.12%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$212.22 - $292.96 $5.74 Million - $7.93 Million	27,064 Added 1.5%	1,833,768 $389 Million
Q2 2024 Aug 13, 2024	BUY	$193.33 - $291.99 $26.7 Million - $40.3 Million	137,898 Added 8.26%	1,806,704 $506 Million
Q1 2024 May 10, 2024	BUY	$171.37 - $283.23 $16.1 Million - $26.6 Million	94,064 Added 5.97%	1,668,806 $446 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $169,041 - $332,930	1,404 Added 0.09%	1,574,742 $364 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $15.7 Million - $24.3 Million	107,816 Added 7.36%	1,573,338 $230 Million
Q2 2023 Aug 14, 2023	BUY	$203.88 - $312.0 $9.65 Million - $14.8 Million	47,349 Added 3.34%	1,465,522 $339 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $35.1 Million - $46.6 Million	151,798 Added 11.99%	1,418,173 $344 Million
Q4 2022 Feb 10, 2023	BUY	$58.39 - $296.54 $704,767 - $3.58 Million	12,070 Added 0.96%	1,266,375 $368 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $1.35 Million - $1.77 Million	22,322 Added 1.81%	1,254,305 $81.5 Million
Q2 2022 Aug 12, 2022	BUY	$58.04 - $100.2 $961,722 - $1.66 Million	16,570 Added 1.36%	1,231,983 $88.2 Million
Q1 2022 May 13, 2022	BUY	$55.89 - $101.89 $5.16 Million - $9.41 Million	92,352 Added 8.22%	1,215,413 $119 Million
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $3.73 Million - $4.9 Million	51,531 Added 4.81%	1,123,061 $95.2 Million
Q3 2021 Nov 12, 2021	BUY	$78.35 - $105.02 $1.74 Million - $2.33 Million	22,220 Added 2.12%	1,071,530 $85.5 Million
Q2 2021 Aug 13, 2021	BUY	$97.2 - $137.59 $102 Million - $144 Million	1,049,310 New	1,049,310 $102 Million

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.28B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Madrigal Pharmaceuticals, Inc. Transaction History